MDA National says a potential surge in patient lawsuits has led it to pull cover for GPs and other private practitioners who initiate hormone therapy for children and teens with gender dysphoria. 

From 1 July, doctors who practise outside of a hospital-based multidisciplinary team will not be covered by the medical defence organisation (MDO) for any future claims that may arise from starting gender-affirming hormones in under-18s. 

Cover will also be denied if a claim eventuates after a private doctor makes an assessment that a child or adolescent “is suitable for gender transition”. 

“We consider it appropriate that the assessment and initial prescribing for patients transitioning under the age of 18 years occurs with the support and management of a multidisciplinary team in a hospital setting,” MDA National said in a statement to affected members.